Literature DB >> 797378

A role for antibody in the expression of cellular immunity to Salmonella typhimurium C5.

R Davies, I Kotlarski.   

Abstract

Immunisation of mice with alcohol-killed Salmonella typhimurium C5 vaccine before infection with Salmonella enteritidis 11RX enhanced the ability of these mice to control and eliminate a challenge dose of Salmonella typhimurium C5, compared to mice which only received live Salmonella enteritidis 11RX organisms. When alcohol-killed Salmonella enteritidis Se795 vaccine was used instead of the Salmonella typhimurium C5 vaccine, this effect was not observed. These observations imply that both humoral and cellular responses are important in the expression of immunity to slamonella infections. The bearing of these results on the observations of other workers is discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 797378     DOI: 10.1038/icb.1976.22

Source DB:  PubMed          Journal:  Aust J Exp Biol Med Sci        ISSN: 0004-945X


  4 in total

1.  Adoptive transfer of immunity to oral challenge with virulent salmonellae in innately susceptible BALB/c mice requires both immune serum and T cells.

Authors:  P Mastroeni; B Villarreal-Ramos; C E Hormaeche
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

2.  Anti-Listeria monocytogenes immunity in mu-suppressed mice: a comparison of treatment with conventional hyperimmune rabbit anti-mouse IgM and affinity-purified, monoclonal rat anti-mouse IgM.

Authors:  A Cerny; A W Hügin; H Bazin; S Sutter; H Hengartner; R M Zinkernagel
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

3.  Immunogenicity of a low-virulence vaccinal strain against Salmonella abortus-ovis infection in mice.

Authors:  F Lantier; P Pardon; J Marly
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

4.  Salmonellosis in mice: studies on oral immunization with live avirulent vaccines.

Authors:  I Moser; A Hohmann; G Schmidt; D Rowley
Journal:  Med Microbiol Immunol       Date:  1980       Impact factor: 3.402

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.